Lee Marie Catherine, Newman Lisa A
Department of Surgery, University of Michigan, 1500 East Medical Center Drive, 3216A Cancer Center/Box 0932, Ann Arbor, MI 48109, USA.
Surg Clin North Am. 2007 Apr;87(2):379-98, ix. doi: 10.1016/j.suc.2007.01.012.
The indications and benefits of postmastectomy radiation therapy (PMRT) continue to evolve. Advances in systemic adjuvant therapy and targeted therapy for breast cancer are likely to play an increasingly important role in control of locoregional as well as distant disease. Ongoing scrutiny of patterns of chest wall failure will be required to define the net benefit derived from PMRT. This article discusses the 2001 American Society of Clinical Oncology guidelines for PMRT and current practices using PMRT in selected groups of patients who have breast cancer.
乳房切除术后放射治疗（PMRT）的适应证和益处仍在不断演变。乳腺癌全身辅助治疗和靶向治疗的进展可能在控制局部区域以及远处疾病方面发挥越来越重要的作用。需要对胸壁复发模式进行持续的仔细研究，以确定PMRT的净获益。本文讨论了2001年美国临床肿瘤学会关于PMRT的指南以及在特定乳腺癌患者群体中使用PMRT的当前实践。
